| Literature DB >> 26777299 |
Simone Di Micco1, Carmela Spatafora2, Nunzio Cardullo2, Raffaele Riccio1, Katrin Fischer3, Carlo Pergola3, Andreas Koeberle3, Oliver Werz3, Malik Chalal4, Dominique Vervandier-Fasseur4, Corrado Tringali2, Giuseppe Bifulco5.
Abstract
2,3-Dihydrobenzofurans are proposed as privileged structures and used as chemical platform to design small compound libraries. By combining molecular docking calculations and experimental verification of biochemical interference, we selected some potential inhibitors of microsomal prostaglandin E2 synthase (mPGES)-1. Starting from low affinity natural product 1, by our combined approach we identified the compounds 19 and 20 with biological activity in the low micromolar range. Our data suggest that the 2,3-dihydrobenzofuran derivatives might be suitable bioinspired lead compounds for development of new generation mPGES-1 inhibitors with increased affinity.Entities:
Keywords: 2,3-Dihydrobenzofuran privileged structure; Cancer; Inflammation; Molecular docking; mPGES-1 inhibitors
Mesh:
Substances:
Year: 2016 PMID: 26777299 DOI: 10.1016/j.bmc.2016.01.002
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641